U S Global Investors Inc Amgen Inc Transaction History

U S Global Investors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $361,800 - $433,512	-2,078 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $23,171 - $27,161	139 Added 7.17%	2,078 $383,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $120,278 - $135,580	-665 Reduced 25.54%	1,939 $368,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $17,787 - $20,053	-96 Reduced 3.56%	2,604 $540,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $33,210 - $37,302	200 Added 8.0%	2,700 $498,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $33,886 - $39,600	200 Added 8.7%	2,500 $426,000
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $388,217 - $433,757	2,300	2,300 $400,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of U S Global Investors Inc, based on Form 13F filings with the SEC.

Stay updated on U S Global Investors Inc with notifications on news.